Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited

668.55
INR
-5.55
(-0.82%)
4.85EPS
159.70P/E
342.14BMarket Cap
Nov 06Next Earn
Krishna Institute of Medical Sciences Limited
NSE:KIMS
(National Stock Exchange of India)

Recent

price

668.55

P/E

ratio

159.70

div

yld

- -

ROIC.AI

2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
22.94
28.06
35.05
41.56
54.17
61.83
75.06
96.77
105.18
Revenue per Share
-1.19
2.98
5.37
8.38
8.41
7.75
9.61
6.03
5.1
Basic EPS, GAAP
1.41
3.74
6.99
3.87
-3.56
-3.15
-10.67
-22.92
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
13.51
14.95
21.59
34.67
41.72
45.69
53.43
56.17
- -
Book Value per Share
10.97
12.17
18.85
31.76
32.08
36.38
43.27
46.28
- -
Tangible Book Value per Share
400
400
374
397
400
400
400
400
401
Basic Weighted Avg Shares
9,180
11,226
13,122
16,508
21,677
24,740
30,035
38,721
42,125
Sales/Revenue/Turnover
13.1
16.1
23.48
26.84
22.22
20.26
20.5
13.83
11.92
Operating Margin (%)
565
706
695
727
1,293
1,465
1,772
2,832
3,306
Depreciation Expense
-478
1,192
2,012
3,327
3,363
3,100
3,845
2,414
2,043
Net Income, GAAP
- -
18.11
26.36
24.75
24.56
26.9
25.68
27.52
29.77
Effective Tax Rate (%)
-5.2
10.62
15.33
20.15
15.52
12.53
12.8
6.23
4.85
Profit Margin (%)
-270
10
1,729
1,784
1,812
954
-1,389
-3,015
- -
Working Capital
2,882
3,143
2,279
2,263
6,336
12,265
22,873
36,374
- -
LT Debt
5,669
6,114
8,762
14,106
19,380
20,931
24,188
25,585
- -
Total Equity
- -
16.07
21.44
23.93
17.93
12.33
11.21
6.55
- -
Return on Invested Capital (%)
- -
16.46
20.12
23.33
15.36
10.49
9.97
6.5
- -
Return on Capital (%)
- -
20.93
27.53
29.56
22
17.73
19.39
11.01
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
6,155
- -
LT Borrowings
- -
26,726
- -
LT Finance Leases
- -
9,648
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
400
400
420
Market Capitalization
243,525
248,686
342,137

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
9,374
- -
Cash, Cash Equivalents & STI
- -
705
- -
Accounts Receivable, Net
- -
5,542
- -
Inventories
- -
969
- -
Total Current Liabilities
- -
12,389
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
6,155
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
25.55%
5.78%
Free Cash Flow
- -
21.61%
114.73%
Net Income, GAAP
- -
9.08%
-37.22%
Sales/Revenue/Turnover
- -
24.31%
28.92%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
6,884
7,773
7,724
7,969
30,035
2026
8,716
9,607
9,977
10,746
38,721
2027
11,795
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
2.16
2.68
2.22
2.54
9.61
2026
1.96
1.67
1.33
1.06
6.03
2027
1.04
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -
Business
Krishna Institute of Medical Sciences Limited (KIMS Hospitals) operates a chain of multi-specialty hospitals providing integrated tertiary and quaternary healthcare services across more than 25 specialties, including cardiac sciences, oncology, neurosciences, gastroenterology, orthopaedics, organ transplantation, renal sciences, mother and child care, neurology, neurosurgery, pulmonology, rheumatology, robotics, urology, critical care, emergency and trauma services, interventional cardiology and oncology, and advanced diagnostics such as MRI, CT scans, and laboratory medicine; the company maintains NABH and NABL accreditations and is listed on the National Stock Exchange of India. Founded in 2000 by Dr. Bhaskar Rao Bollineni with its first hospital in Nellore, Andhra Pradesh, KIMS Hospitals is headquartered in Secunderabad, Telangana, and serves patients primarily in tier-2 and tier-3 cities across Telangana, Andhra Pradesh, Maharashtra, Kerala, Karnataka, with a network exceeding 8,300 beds including its flagship 1,000-bed facility in Secunderabad. Recent expansions include new hospitals in Nashik (Maharashtra, 2024), Kannur (Kerala, 2024), Guntur (Andhra Pradesh, 2025), Sangli (Maharashtra, 2025 via partnership with UAIMS Hospital including a call option for majority stake), Kollam (Kerala, 2025), Thane (Maharashtra, 2025), and Bangalore (Karnataka, 2025 with a 450-bed multi-specialty facility); acquisitions such as Chalasani Hospitals in Visakhapatnam (2024 for Rs 28 crore), Kingsway Hospital in Nagpur (2022), and others like AsianTranscare and MIPPL in Hyderabad (2024); launches of advanced services including AI-based early warning systems (2025), paediatric cardiac surgery, ECMO, liver transplants, cancer centres, and expansions adding over 1,500 beds in locations like Bengaluru, Ongole, Anantapur, Kondapur, and Rajahmundry.